EFDID: 506694EFD: View Filing

Issuer: Apogem Secondary Fund VII, LP (0001979709) - D

Accession: 0001979709-24-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Apogem Secondary Fund VII, LP
  • Entity Type:
    Limited Partnership
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2023)
  • Address:
    299 Park Avenue
    37th Floor

    New York, NY 10171
  • Persons:
    Related Persons 6
    N/A ASF VII GP, LLC
    Director 
    General Partner of the Issuer
    John M Grady
    Executive Officer 
    Chief Financial Officer of Apogem Capital LLC, the Issuer's Investment Manager
    Christopher Stringer
    Executive Officer 
    Managing Director and Head of Private Equity of Apogem Capital LLC, the Issuer's Investment Manager
    N/A Apogem Capital LLC
    Promoter 
    Investment Manager
    Michael Zeleniuch
    Executive Officer 
    Managing Director of Apogem Capital LLC, the Issuer's Investment Manager
    Michael Griech
    Executive Officer 
    Managing Director of Apogem Capital LLC, the Issuer's Investment Manager
EDGAR: Offering Information
  • Accession Date:
    01/10/2024
  • First Sale Date:
    12/26/2023
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $451,161,616
  • Exemptions:
    Section 3(c)(7), Investment Company Act Section 3(c) , Rule 506
  • Security Type(s):
    Pooled Investment Fund
EFD: Current State Notices

Notices found in EFD

Filed:AZ, CA, DE, GA, IA, IL, IN, KS, LA, MA, MI, MN, MO, NJ, NV, NY, OH, PA, RI, SD, TX, UT, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
NYLIFE Distributors LLC 35350 None None All States
Alvine Capital Management Limited None None None
Alvine Capital AB (ACAB) None None None
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Apogem Secondary Fund VII, LP/s/ John M. GradyJohn M. GradyCFO of Apogem Capital LLC, the Issuer's Investment Manager2024-01-10
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Feb. 13, 2026 506694: 0001979709-26-000003 Apogem Secondary Fund VII, LP
Offer Amount: $1,300,000,000
Amount Sold: $1,213,716,946
Remaining: $86,283,054
D/A Feb. 14, 2025 506694: 0001979709-25-000001 Apogem Secondary Fund VII, LP
Offer Amount: $1,300,000,000
Amount Sold: $776,170,201
Remaining: $523,829,799
D Jan. 10, 2024 506694: 0001979709-24-000001 Apogem Secondary Fund VII, LP
Amount Sold: $451,161,616